Vijay Kumar
Stock Analyst at Evercore ISI Group
(2.41)
# 2,567
Out of 5,024 analysts
262
Total ratings
47.44%
Success rate
-1.74%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: In-Line | $106 → $104 | $98.37 | +5.72% | 14 | Oct 7, 2025 | |
| TWST Twist Bioscience | Maintains: Outperform | $46 → $42 | $30.55 | +37.48% | 6 | Oct 7, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $525 → $590 | $525.83 | +12.20% | 13 | Oct 7, 2025 | |
| SYK Stryker | Maintains: Outperform | $418 → $410 | $370.00 | +10.81% | 12 | Oct 7, 2025 | |
| RVTY Revvity | Maintains: Outperform | $108 → $106 | $91.14 | +16.30% | 3 | Oct 7, 2025 | |
| PEN Penumbra | Maintains: Outperform | $300 → $285 | $254.94 | +11.79% | 2 | Oct 7, 2025 | |
| MTD Mettler-Toledo International | Maintains: Outperform | $1,275 → $1,400 | $1,303.04 | +7.44% | 12 | Oct 7, 2025 | |
| ISRG Intuitive Surgical | Maintains: In-Line | $535 → $450 | $436.39 | +3.12% | 14 | Oct 7, 2025 | |
| IRTC iRhythm Technologies | Maintains: In-Line | $185 → $175 | $176.84 | -1.04% | 2 | Oct 7, 2025 | |
| ILMN Illumina | Maintains: Outperform | $135 → $132 | $91.00 | +45.05% | 8 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $68 | $60.56 | +12.29% | 7 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $226 → $245 | $206.15 | +18.85% | 4 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $110 | $96.24 | +14.30% | 7 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $17 | $15.13 | +12.36% | 10 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $31 | $22.82 | +35.85% | 8 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $140 → $144 | $133.27 | +8.05% | 16 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $128 → $140 | $138.04 | +1.42% | 7 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $80 → $88 | $73.36 | +19.96% | 14 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $69 → $78 | $65.92 | +18.33% | 16 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $49 → $54 | $47.09 | +14.67% | 7 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $159 → $155 | $139.37 | +11.21% | 7 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $40 | $30.36 | +31.75% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $35 → $33 | $30.63 | +7.74% | 8 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $16 | $13.91 | +15.03% | 11 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $103 → $106 | $96.54 | +9.80% | 5 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $46 | $31.06 | +48.10% | 4 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $3 | $3.06 | -1.80% | 6 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $96 → $85 | $72.34 | +17.50% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $18 → $30 | $13.17 | +127.79% | 11 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $333.14 | +6.56% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $71.48 | +123.84% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $188.36 | +53.96% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $2.05 | +241.46% | 1 | May 31, 2022 |
Zimmer Biomet Holdings
Oct 7, 2025
Maintains: In-Line
Price Target: $106 → $104
Current: $98.37
Upside: +5.72%
Twist Bioscience
Oct 7, 2025
Maintains: Outperform
Price Target: $46 → $42
Current: $30.55
Upside: +37.48%
Thermo Fisher Scientific
Oct 7, 2025
Maintains: Outperform
Price Target: $525 → $590
Current: $525.83
Upside: +12.20%
Stryker
Oct 7, 2025
Maintains: Outperform
Price Target: $418 → $410
Current: $370.00
Upside: +10.81%
Revvity
Oct 7, 2025
Maintains: Outperform
Price Target: $108 → $106
Current: $91.14
Upside: +16.30%
Penumbra
Oct 7, 2025
Maintains: Outperform
Price Target: $300 → $285
Current: $254.94
Upside: +11.79%
Mettler-Toledo International
Oct 7, 2025
Maintains: Outperform
Price Target: $1,275 → $1,400
Current: $1,303.04
Upside: +7.44%
Intuitive Surgical
Oct 7, 2025
Maintains: In-Line
Price Target: $535 → $450
Current: $436.39
Upside: +3.12%
iRhythm Technologies
Oct 7, 2025
Maintains: In-Line
Price Target: $185 → $175
Current: $176.84
Upside: -1.04%
Illumina
Oct 7, 2025
Maintains: Outperform
Price Target: $135 → $132
Current: $91.00
Upside: +45.05%
Oct 7, 2025
Maintains: Outperform
Price Target: $64 → $68
Current: $60.56
Upside: +12.29%
Oct 7, 2025
Maintains: Outperform
Price Target: $226 → $245
Current: $206.15
Upside: +18.85%
Oct 7, 2025
Maintains: Outperform
Price Target: $115 → $110
Current: $96.24
Upside: +14.30%
Oct 7, 2025
Maintains: Outperform
Price Target: $17 → $17
Current: $15.13
Upside: +12.36%
Oct 7, 2025
Maintains: Outperform
Price Target: $33 → $31
Current: $22.82
Upside: +35.85%
Oct 7, 2025
Maintains: Outperform
Price Target: $140 → $144
Current: $133.27
Upside: +8.05%
Oct 7, 2025
Maintains: In-Line
Price Target: $128 → $140
Current: $138.04
Upside: +1.42%
Oct 7, 2025
Upgrades: Outperform
Price Target: $80 → $88
Current: $73.36
Upside: +19.96%
Oct 7, 2025
Upgrades: Outperform
Price Target: $69 → $78
Current: $65.92
Upside: +18.33%
Sep 30, 2025
Maintains: In-Line
Price Target: $49 → $54
Current: $47.09
Upside: +14.67%
Sep 30, 2025
Maintains: Outperform
Price Target: $159 → $155
Current: $139.37
Upside: +11.21%
Aug 13, 2025
Maintains: Outperform
Price Target: $33 → $40
Current: $30.36
Upside: +31.75%
Aug 5, 2025
Maintains: In-Line
Price Target: $35 → $33
Current: $30.63
Upside: +7.74%
Aug 4, 2025
Maintains: Outperform
Price Target: $18 → $16
Current: $13.91
Upside: +15.03%
Jul 8, 2025
Maintains: Outperform
Price Target: $103 → $106
Current: $96.54
Upside: +9.80%
Jul 8, 2025
Maintains: Outperform
Price Target: $48 → $46
Current: $31.06
Upside: +48.10%
May 19, 2025
Maintains: In-Line
Price Target: $3
Current: $3.06
Upside: -1.80%
May 1, 2025
Maintains: Outperform
Price Target: $96 → $85
Current: $72.34
Upside: +17.50%
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $13.17
Upside: +127.79%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $333.14
Upside: +6.56%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $71.48
Upside: +123.84%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $188.36
Upside: +53.96%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $2.05
Upside: +241.46%